ePrints

Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community

Lookup NU author(s): Dr Paul Mackin, Helen Watkinson, Dr Peter GallagherORCiD, Emeritus Professor Nicol Ferrier

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Background: Prevalence of physical comorbidity in severe mental illness is a significant public health concern, but comparative data in people with diagnoses other than schizophrenia are sparse. Aims: To investigate the prevalence of metabolic disease and cardiovascular risk in people with severe mental illness treated with antipsychotics in the community. Methods: Case-control study of 90 people treated with antipsychotics in the community and 92 age- and gender-matched controls. The prevalence of metabolic syndrome and 10-year cardiovascular risk were calculated. Results: People on antipsychotics had a significantly worse metabolic profile than controls (F=6.583, d.f.=15,161, P < 0.0001). Moreover, metabolic syndrome was more prevalent (OR=3.68, 95% CI 1.71-7.93, P=0.001), as was cardiovascular risk across a number of outcomes. These results are consistent across diagnostic groups. Conclusions: People with severe mental illness treated with antipsychotics have excess metabolic dysfunction and heightened risk for cardiovascular disease.

Publication metadata

Author(s): Mackin P, Bishop D, Watkinson H, Gallagher P, Ferrier IN

Publication type: Article

Publication status: Published

Journal: British Journal of Psychiatry

Year: 2007

Volume: 191

Pages: 23-29

Print publication date: 01/07/2007

ISSN (print): 0007-1250

ISSN (electronic): 1472-1465

Publisher: Royal College of Psychiatrists

URL: http://dx.doi.org/10.1192/bjp.bp.106.031716

DOI: 10.1192/bjp.bp.106.031716

PubMed id: 17602121

Altmetrics

Share